AR and urinary bladder cancer: Interestingly, bladder cancer developed in 50% and 25% of castrated male mice and ARKO male mice supplemented with DHT [30], suggesting the involvement of AR pathway activated by non-androgens or low levels of androgens and non-AR pathways mediated by androgens, respectively, in urothelial carcinogenesis.